Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition

Abstract

The epithelium to mesenchyme transition is thought to play a fundamental role during embryonic development and tumor progression. Loss of cell–cell adhesion and modification of both cell morphology and gene expression are the main events associated with this transition. There is a large amount of evidence suggesting that growth factors can initiate these events. Yet, the connection from growth factor induction to changes in cell adhesion and morphology is largely unknown. To elucidate this connection, we have investigated the action of IGF-II on E-cadherin/β-catenin complex-mediated cell–cell adhesion and on β-catenin/TCF-3 mediated gene expression. We can show that (1) IGF-II induces a rapid epithelium to mesenchymal transition; (2) IGF1R, the receptor for IGF-II, belongs to the same membrane complex as E-cadherin and β-catenin; (3) IGF-II induces a redistribution of β-catenin from the plasma membrane to the nucleus and an intracellular sequestration and degradation of E-cadherin; (4) IGF-II induces the transcription of β-catenin/TCF-3 target genes. Based on the given case of IGF-II and E-cadherin/β-catenin complex, this study reveals the backbone of a cascade connecting growth factor signaling with cell–cell adhesion during EMT.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Aberle H, Schwartz H, Kemler R . 1996 J. Cell. Biochem. 61: 514–523

  • Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA . 1996 EMBO J. 15: 6541–6551

  • André F, Rigot V, Thimonier J, Montixi C, Parat F, Pommier G, Marvaldi J, Luis J . 1999 Int. J. Cancer 83: 497–505

  • Aoki M, Hecht A, Kruse U, Kemler R, Vogt PK . 1999 Proc. Natl. Acad. Sci. (USA) 96: 139–144

  • Baker J, Liu JP, Robertson EJ, Efstratiadis A . 1993 Cell 75: 73–82

  • Baserga R . 1999 Exp. Cell. Res. 253: 1–6

  • Baserga R, Morrione A . 1999 J. Cell. Biochem. 32: 68–75

  • Bauer A, Huber O, Kemler R . 1998a Proc. Natl. Acad. Sci. (USA) 95: 14787–14792

  • Bauer A, Lickert H, Kemler R, Stappert J . 1998b J. Biol. Chem. 273: 28314–28321

  • Behrens J . 2000 Ann. NY Acad. Sci. 910: 21–33

  • Birchmeier C, Birchmeier W, Brand-Saberi B . 1996 Acta Anat. 156: 217–226

  • Birchmeier W, Behrens J . 1994 Biochim. Biophys. Acta 1198: 11–26

  • Blakesley VA, Butler AA, Koval AP, Okubo Y, LeRoith D . 1999 Contemporary Endocrinology: The IGF System, Molecular Biology, Physiology and Clinical Applications Vol. 7. Rosenfeld RG, Roberts Jnr CT (eds.) Humana Press, Inc.: Totowa, NJ pp. 143–163

    Google Scholar 

  • Boyer B, Dufour S, Thiery JP . 1992 Exp. Cell. Res. 201: 347–357

  • Boyer B, Valles AM, Edme N . 2000 Biochem. Pharmacol. 60: 1091–1099

  • Butz S, Larue L . 1995 Cell. Adhes. Comm. 3: 337–352

  • Cepek KL, Shaw SK, Parker CM, Russell GJ, Morrow JS, Rimm DL, Brenner MB . 1994 Nature 372: 190–193

  • Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA . 1995 Nature 378: 785–789

  • Delmas V, Pla P, Feracci H, Thiery JP, Kemler R, Larue L . 1999 Dev. Biol. 216: 491–506

  • Eger A, Stockinger A, Schaffhauser B, Beug H, Foisner R . 2000 J. Cell. Biol. 148: 173–188

  • Germain-Lee EL, Janicot M, Lammers R, Ullrich A, Casella SJ . 1992 Biochem. J. 281: 413–417

  • Greaves S, Sanson B, White P, Vincent JP . 1999 Genetics 153: 1753–1766

  • Guvakova MA, Surmacz E . 1997 Exp. Cell. Res. 231: 149–162

  • Honing S, Hunziker W . 1995 J. Cell. Biol. 128: 321–332

  • Hoschuetzky H, Aberle H, Kemler R . 1994 J. Cell. Biol. 127: 1375–1380

  • Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R . 1996 Mech. Dev. 59: 3–10

  • Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D . 1991 Cell 66: 1095–1104

  • Larue L, Antos C, Butz S, Huber O, Delmas V, Dominis M, Kemler R . 1996 Development 122: 3185–3194

  • Le TL, Yap AS, Stow JL . 1999 J. Cell. Biol. 146: 219–232

  • Lin FT, Daaka Y, Lefkowitz RJ . 1998 J. Biol. Chem. 273: 31640–31643

  • Louvi A, Accili D, Efstratiadis A . 1997 Dev. Biol. 189: 33–48

  • Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S, Takeichi M . 1992 J. Cell. Biol. 118: 703–714

  • Miller JR, Hocking AM, Brown JD, Moon RT . 1999 Oncogene 18: 7860–7872

  • Morali O, Jouneau A, McLaughlin KJ, Thiery JP, Larue L . 2000 Dev. Biol. 227: 133–145

  • Morin PJ . 1999 Bioessays 21: 1021–1030

  • Muller T, Choidas A, Reichmann E, Ullrich A . 1999 J. Biol. Chem. 274: 10173–10183

  • Nollet F, Kools P, van Roy F . 2000 J. Mol. Biol. 299: 551–572

  • Ozawa M, Baribault H, Kemler R . 1989 EMBO J. 8: 1711–1717

  • Pasdar M, Nelson WJ . 1988 J. Cell. Biol. 106: 677–685

  • Peifer M, Polakis P . 2000 Science 287: 1606–1609

  • Peifer M, Wieschaus E . 1990 Cell 63: 1167–1176

  • Playford MP, Bicknell D, Bodmer WF, Macaulay VM . 2000 Proc. Natl. Acad. Sci. (USA) 97: 12103–12108

  • Redies C, Takeichi M . 1996 Dev. Biol. 180: 413–423

  • Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P . 1996 Science 272: 1023–1026

  • Sanson B, White P, Vincent JP . 1996 Nature 383: 627–630

  • Shiozaki H, Kadowaki T, Doki Y, Inoue M, Tamura S, Oka H, Iwazawa T, Matsui S, Shimaya K, Takeichi M, Moden M. et al . 1995 Br. J. Cancer 71: 250–258

  • van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J, Ypma A, Hursh D, Jones T, Bejsovec A, Peifer M, Mortin M, Clevers H . 1997 Cell 88: 789–799

  • Yagi T, Takeichi M . 2000 Genes Dev. 14: 1169–1180

Download references

Acknowledgements

We wish to thank H Clevers and R Kemler for the Top-Fop flash plasmids, J Camonis for the two-hybrid system kit, W Birchmeier for the TCF-3 antibody, and H Hoschuetzky for the H2Kd antibody. We are grateful to A Ben Ze'ev, M Guvakova, J Salamero, E Surmacz, and A Taddei for helpful discussions. We thank B Boyer, J Jouanneau, I Tratner and AM Vallès for providing comments on the manuscript. This work was supported by grants from Association Française contre les Myopathies (#6864), the Association sur la Recherche contre le Cancer (#9991) and by the Ligue contre le Cancer-Yvelines (GL/MM 298/99). O Morali and R Moore were supported by grants from AFM and FRM, respectively.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lionel Larue.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morali, O., Delmas, V., Moore, R. et al. IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 20, 4942–4950 (2001). https://doi.org/10.1038/sj.onc.1204660

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204660

Keywords

This article is cited by

Search

Quick links